# Biocomposites acquires remaining shares of SYNICEM and Subiton manufacturers

Biocomposites acquired the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L., gaining full control of the SYNICEM and Subiton antibiotic bone cement product ranges.

- Type: Acquisition
- Announced: 2024-09-18
- Status: completed
- Products: antibiotic bone cements, preformed antibiotic-loaded spacers
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Biocomposites](https://endata.com/companies/61765.md) (acquirer)
- [Laboratorios SL](https://endata.com/companies/79903.md) (target)
- [Synergie Ingénierie Médicale](https://endata.com/companies/79904.md) (target)

## Sources

- [biocomposites.com](https://biocomposites.com/news/biocomposites-acquires-remaining-shares-in-manufacturer-of-synicem-and-subiton-products/), 2024-09-18: "Biocomposites is pleased to announce the acquisition of the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L. – gaining full control of the SYNICEM TM and Subiton product ranges."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.